ArticleFrontiers in artificial intelligence2026
Frequency response compensation to optimize pretrained deep learning models in lung nodule malignancy classification.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Accurate differentiation of benign and malignant pulmonary nodules on computed tomography (CT) is important for early lung-cancer assessment. However, classification remains challenging because benign and malignant nodules may exhibit subtle differences in texture, margin irregularity, boundary sharpness, and internal morphology that may not be fully represented by conventional convolutional feature extraction. Methods: A frequency response Bilinear Lag-Lead (BT-LL) EfficientNetB3 framework was developed for benign-malignant pulmonary nodule classification. The proposed approach integrates Lag-Lead frequency compensation into the pretrained feature-extraction process to refine intermediate representations. The Lag component performs structural smoothing to preserve low-frequency information, whereas the Lead component enhances high-frequency boundary and texture characteristics. These corresponding representations are integrated with the original feature maps through a dedicated fusion operation to obtain frequency-refined features for classification. The compensation filters are fixed, thereby avoiding additional parameter learning within the filtering operation. Patient-level data partitioning was used to ensure that nodules from the same patient were not distributed across different experimental subsets, reducing the risk of information leakage. Results: The proposed model achieved an accuracy, sensitivity, and specificity of 0.90, an F1-score of 0.81, and an AUROC of 0.95 on the held-out patient-level test set. Performance was additionally assessed using patient-level cross-validation, cross imbalance analysis, an IQ-OTH/NCCD image-level evaluation and an independent BUS-BRA patient-level evaluation. The experimental analysis further included statistical significance testing using McNemar's test for pairwise model comparisons, followed by the Holm correction to control for multiple comparisons, while Cochran's Q test was employed to assess performance differences across multiple model configurations. The combined configuration achieved the best sensitivity and balanced accuracy relative to the branch-wise variants. The Bilinear Lag-Lead (BT-LL) framework thus provides an explicit, frequency response mechanism for integrating contributions of low- and high-frequency information in pulmonary nodule representations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.